評論
打印
UPI reports Food and Drug Administration has approved a prescription-only nasal spray to treat depression
UPI報道稱食品藥品監督管理局（FDA）批準了鼻腔噴霧劑可用于治療抑郁癥
marking the first medical advancement in fighting the affliction in more than 30 years.
標志著30多年來在抗擊抑郁癥上取得的首次醫學進步。
The agency approved Johnson & Johnson's Spravato, which will carry the FDA's strongest box warning due to abuse potential.
管理局批準了美國強生的Spravato，由于其濫用潛力，Spravato將被貼有FDA最強的方框警告。
FDA Dr. Tiffany Farchione said in a statement
FDA的Tiffany Farchione博士在聲明中表示
"There has been a long-standing need for additional effective treatments for treatment-resistant depression, a serious and life-threatening condition."
“長期以來我們都需要附加有效的方法來治療耐藥性抑郁癥，這是一種嚴重且會危及生命的疾病。”
譯文屬可可英語原創，未經允許，不得轉載。
